Just shared some thoughts in the chat. I’m officially out of this one. It’s simply become too precarious and isn’t worth the opportunity cost given the complete lack of progress in turning this around, and mgmt’s failure to execute.
Sold out recently. I still really like it, could re-enter, and suspect it does well...but just have some other ideas that I'd rather be in. Pure opportunity cost thing.
Thanks for the update! Have you looked at TLIS? They plan to liquidate via Chapter 11 or 7.
I don't understand the stock action given the cash position ($59.9M as of June-30 ~ $15.70/share assuming conversion of the Series I Preferred) subject to (i) an outstanding (Chicago office?) lease; (ii) $1.9M key employee retention costs; and (iii) two lawsuits.
I must confess that I haven't had the stamina to read through the NI 43-101, could you roughly point out the data you used to get to that ARR figure?
Disappointing results for SPWH. with the slashed guidance, the path forward definitely becomes less clear.
Just shared some thoughts in the chat. I’m officially out of this one. It’s simply become too precarious and isn’t worth the opportunity cost given the complete lack of progress in turning this around, and mgmt’s failure to execute.
Hi! Still in Roivant?
Sold out recently. I still really like it, could re-enter, and suspect it does well...but just have some other ideas that I'd rather be in. Pure opportunity cost thing.
Thanks for the update! Have you looked at TLIS? They plan to liquidate via Chapter 11 or 7.
I don't understand the stock action given the cash position ($59.9M as of June-30 ~ $15.70/share assuming conversion of the Series I Preferred) subject to (i) an outstanding (Chicago office?) lease; (ii) $1.9M key employee retention costs; and (iii) two lawsuits.
Know a few people in it, but I am only vaguely familiar.